Frequently Asked Questions

A reasonable suspicion checklist can be invaluable for employers, particularly in maintaining a safe, productive, and drug-free workplace, and provides guidelines for recognizing and addressing situations where there's reasonable suspicion of an employee's drug or alcohol impairment, all employers need to understand its role, implementation, and potential benefits.

In employment, reasonable suspicion is a legal standard employers use when they believe an employee might be impaired due to drug or alcohol use. The suspicion is usually based on direct observations, such as appearance, behavior, speech, or body odors, and identifying these signs can be challenging, especially when balancing respect for employees' privacy and maintaining a safe work environment, where a reasonable suspicion checklist comes into play.

Using a checklist for reasonable suspicion determinations offers a systematic way to observe and document signs of possible substance abuse, which assists employers in making informed decisions, and a list typically outlines physical, behavioral, and performance indicators of potential impairment. For example, sudden changes in work performance, unusual behavior, or physical signs such as bloodshot eyes could all indicate substance abuse, and by providing a structured format to note down and assess these factors, the checklist aids in ensuring that the decision to test an employee is indeed 'reasonable' and not arbitrary, biased, or unfounded.

Checklists also promote consistency and fairness in dealing with suspected substance abuse cases, and every manager or supervisor uses the same criteria for identifying signs of impairment. In that case, it helps prevent unfair targeting of individuals and ensures everyone is treated equally, and consistency is crucial in avoiding legal complications arising from perceived discrimination or violating an employee's rights.

Another significant benefit of using a reasonable suspicion checklist is its role in fostering a safer workplace, and when effectively used, the checklist can help identify employees who may pose a risk to themselves or others due to impairment, and by these situations promptly, employers can prevent accidents, injuries, and other safety issues, protecting the company and its employees.

We invite you to download our free checklist to create a safer, more respectful workplace. It's a practical, user-friendly tool designed to help employers navigate the complex process of identifying and handling suspected substance abuse in the workplace, and by providing clear guidance and promoting a standardized approach, our checklist empowers you to address these sensitive issues with certainty and compassion.

The free checklist is not a substitute for legal advice. Always consult an attorney for your unique situation.

A career as a DOT specimen collector offers a promising opportunity for individuals keen on pursuing a profession in the healthcare and substance abuse industry. In this role, collectors gather and manage biological samples like urine, hair, or saliva for drug and alcohol testing. While the primary focus is conducting Department of Transportation (DOT) mandated tests, responsibilities may also extend to non-DOT testing, providing a diverse and engaging work environment.

One of the standout features of this career path is its potential as a stepping stone into substance abuse prevention. Starting as a qualified collector can serve as a launchpad for further advancement, opening doors to positions such as Substance Abuse Counselor, DER Program Manager, or other roles within healthcare management.

The U.S. Bureau of Labor Statistics (BLS) does not publish wage data for drug test specimen collectors as a separate occupation. The closest BLS occupation is Phlebotomists (SOC 31-9097). In May 2025, the median annual wage for phlebotomists was $45,230. The lowest 10 percent earned less than $35,780, and the highest 10 percent earned more than $58,780 (BLS, Occupational Employment and Wage Statistics, May 2025). Pay varies by location and employer.

To become a certified collector, individuals must undergo specialized training and meet the DOT qualification requirements. This training provides learners with the necessary skills and knowledge to perform specimen collection with accuracy and professionalism. Earning a qualification and certification with Learn Laws® involves passing an exam demonstrating competence in conducting drug and alcohol tests following established protocols.

The career outlook for professionals in this industry is optimistic, driven by an increasing demand for substance abuse experts, particularly in light of growing societal awareness and concerns regarding drug and alcohol abuse. Healthcare-related jobs, including positions like Specimen Collector, offer stability and are less susceptible to economic fluctuations than other industries. Prioritizing the acquisition of the necessary knowledge and skills to become certified collectors before embarking on their job search is essential. This will enhance competitiveness and open up better employment opportunities, leading to higher salary expectations.

Working as a collector lays a strong foundation for those aspiring to build a fulfilling career in substance abuse prevention. With steady demand for trained collectors and avenues for career growth, this profession blends technical expertise, interpersonal interactions, and opportunities for professional development, making it a gratifying and rewarding career path.

Employers conduct drug and alcohol testing to ensure a safe and productive workplace environment because drug and alcohol use can impair an employee's ability to function properly at work, leading to potential accidents, lowered productivity, and other adverse consequences, and in industries such as transportation where safety is paramount, drug and alcohol testing is not only important but mandated by regulatory bodies like the U.S. Department of Transportation (DOT).

DOT-regulated drug and alcohol testing follows a federally standardized set of guidelines for safety-sensitive positions in the transportation sector, which includes roles such as truck drivers, airline pilots, and ship captains, where substance impairment could lead to serious accidents. The testing procedures, substances screened, and the handling of violations are regulated under U.S. Department of Transportation rules.

Non-DOT drug and alcohol testing operates within the boundaries set by state laws and the specific policies of individual companies. This type of testing applies to diverse roles beyond the transportation sector, including professions such as administrative staff in corporate offices, construction workers navigating potential job site hazards, and hotel personnel providing essential customer services. While the testing protocols for Non-DOT roles vary considerably, mirroring the unique safety and operational requirements across different industries and regions, they share a common goal of workplace safety, productivity, and compliance with local regulations.

DOT-regulated employers must follow strict federal guidelines for safety-sensitive roles where impaired functioning could precipitate severe, potentially life-threatening accidents. These roles that employers conduct drug and alcohol testing for include but are not limited to:

• Supervisory Personnel: Supervisors in transportation sectors, such as fleet managers, aviation supervisors, rail operation overseers, transit system coordinators, and maritime officers, bear significant responsibilities. Their roles manage and direct safety-sensitive roles, influencing the safety and productivity of entire teams. Whether it's a supervisor of commercial motor vehicle drivers ensuring regulatory compliance, an aviation supervisor maintaining rigorous safety protocols, or a maritime officer overseeing a ship's operations, their decisions and actions have far-reaching implications. Supervisors who also perform safety-sensitive functions, such as a manager who drives a commercial motor vehicle, are subject to the same DOT testing as the employees they supervise.
• Commercial Motor Vehicle Drivers: This encompasses roles such as interstate truck drivers, school bus drivers, and those responsible for transporting hazardous materials. It also includes individuals who operate vehicles capable of carrying 16 or more passengers. These professionals navigate our roads and highways, their performance directly influencing the safety of numerous lives.
• Aviation Personnel: Airline pilots, flight attendants, and flight instructors play crucial roles in safeguarding air travel. Their positions require sharp skills, strict adherence to protocols, and a high level of responsibility given the potential risks involved in aviation.
• Train Operators and Dispatchers: Similar to aviation, the rail industry carries significant safety responsibilities. Train operators and dispatchers are critical to the smooth and safe operation of rail networks, managing large machines and intricate logistics.
• Transit Vehicle Operators: This category includes drivers of diverse public transportation systems, from city buses and vans to trams and subways. Their role in ensuring the safe transit of millions of passengers daily underscores their importance in urban life.
• Ship Captains and Crew Members: In civilian or commercial maritime positions, the captain and crew are fundamental to safe seafaring operations. Their roles are challenging, demanding a keen understanding of nautical navigation and vessel operation. Mariners are tested under U.S. Coast Guard rules (46 CFR Parts 4 and 16). The Coast Guard is part of the Department of Homeland Security, and its drug testing follows 49 CFR Part 40.
• Pipeline Emergency Response Personnel: These individuals handle high-risk situations associated with the transportation of hazardous materials via pipelines. They must maintain a clear head and prompt response times to avert or manage any crises.
• Maintenance and Armed Security Personnel: Roles involving the upkeep of transportation vehicles or the security of transportation operations are also classified as safety-sensitive. These professionals ensure the reliability of our transportation systems and the security of both the systems and their operators.

Employers must adhere to the legal frameworks of drug testing in the workplace, ensuring proper qualification and implementation to avoid discrimination lawsuits or privacy rights violations. A key part of this is appointing a Designated Employer Representative (DER) responsible for managing the drug and alcohol testing program, liaising with testing laboratories, and ensuring compliance with regulations.

Workplace supervisors should be proficiently trained in "reasonable suspicion" drug testing. This process requires understanding the signs and behaviors indicating potential substance misuse by an employee, and proper training promotes fair identification based on observable facts rather than personal biases, thereby preserving the integrity of the workplace and mitigating legal risks.

Potential lawsuits could arise if a company inconsistently enforces drug testing based on employees' race, age, gender, or disability or fails to accommodate those using legally prescribed medications or dealing with addictions, potentially classified as disabilities. A lack of consistency in reasonable suspicion drug testing procedures may lead to perceived bias, creating legal vulnerabilities, which is why employers must strictly adhere to all relevant federal, state, and local drug testing laws, to maintain a safe workplace, respect employee rights, and mitigate the risk of lawsuits.

Implementing an employer's drug testing strategy should be governed by principles of consistency, fairness, and respect for employees' legal rights, and it is crucial that testing is applied uniformly, devoid of any discriminatory practices that could infringe upon the rights of employees. 

The U.S. Department of Transportation (DOT) has established procedures and training requirements for those wanting to become qualified specimen collectors for drug testing, learners must follow these steps:

1. Familiarize with 49 CFR Part 40: This part of the Code of Federal Regulations establishes how DOT drug and alcohol testing must be conducted. Collectors need to understand and adhere to these guidelines.

2. Training: Complete a DOT collector training program which must cover the following:

   • All steps to correctly collect a urine specimen, as detailed in 49 CFR Part 40.
   • The importance of maintaining the integrity and security of the specimen collection process.
   • How to handle situations such as shy bladder, tampering attempts, or refusals to test.
   • Mock collections, in which the trainee demonstrates proficiency in urine collection under various scenarios.

3. Qualification Training and Initial Proficiency Demonstration: The training should include:

   • Five consecutive error-free mock collections (49 CFR 40.33(c)):
     • Two uneventful collections
     • One with an insufficient quantity of urine (shy bladder)
     • One with a temperature out of range
     • One where the employee refuses to sign the CCF and initial the specimen bottle tamper-evident seal

4. Documentation: Obtain a certificate or letter of completion from a training company, like Learn Laws®, showing that the collector completed training and mock collections. Collectors should keep this documentation and provide a copy to any employers or service agents that request it (49 CFR 40.33(g)).

5. Error Correction and Refresher Training: A collector who makes a mistake that causes a test to be cancelled (a fatal or uncorrected flaw) must complete error correction training within 30 days of being notified of the error (49 CFR 40.33(f)). Even if no errors are made, collectors must complete refresher training every five years, including another round of mock collections (49 CFR 40.33(e)).

6. Maintain Professional Conduct: Collectors must act professionally and protect the Donor's privacy at all times. Any deviation from protocol or misconduct could lead to disqualification.

7. Stay Updated: Regulations, best practices, and technologies related to drug testing can change. It's crucial to stay informed about any updates to DOT regulations or procedures related to drug specimen collection, which is why mock collections are required every five years.

Another important consideration when trying to become a DOT Collector for urine, breath alcohol, and oral fluid is selecting a reputable training provider for drug and alcohol tests is crucial because a credible provider ensures compliance with 49 CFR Part 40 and ensures that learners have the most up-to-date training content which ensures tests are conducted uniformly and legally following proper chain of custody procedures. 

While hiring "cheap" or "discount" providers is enticing, inadequate training can lead to compromised test results, like false positives or negatives, and such errors can bring legal challenges, including lawsuits and fines, damaging a company's and the industry's reputation, especially in sectors like transportation, errors can pose severe safety risks, and any mishandled test can result in financial burdens due to necessary retests.

Performing a DOT drug test involves specific procedures and protocols to ensure accuracy, confidentiality, and compliance with the U.S. Department of Transportation (DOT) regulations. The most important requirement is proper training to conduct drug and alcohol testing.

Here are the key requirements for conducting a DOT-regulated drug test:

1. Collection Site:

   • The collection site must be secure and private. It should be equipped to prevent tampering with specimens.
   • Ensure there is a facility for washing hands, and the person being tested must show that they have nothing on them that could alter the sample.
   • The same applies to specimen collectors who conduct mobile drug testing.

2. Qualified Personnel:

   • Only a trained and qualified collector can handle and oversee the collection process. The collector must understand the current federal drug testing regulations and guidelines.

3. Chain of Custody Form (CCF):

   • A CCF is required for every sample. This document tracks the specimen by documenting every step from collection to laboratory testing, ensuring no tampering has occurred.

4. Collection Procedure:

   • The tested employee must provide a specific amount of urine in a collection container.
   • The collector checks the specimen for temperature and signs of tampering shortly after collection.
   • The specimen is then poured into two bottles (A and B) and sealed.

5. Laboratory Testing:

   • Only Substance Abuse and Mental Health Services Administration (SAMHSA) certified laboratories can test DOT drug samples.
   • The initial test is an immunoassay. If this test is positive, the laboratory performs a confirmation test using mass spectrometry, such as Gas Chromatography/Mass Spectrometry (GC/MS) or Liquid Chromatography/Tandem Mass Spectrometry (LC-MS/MS).

6. Tested Substances:

   • The U.S. Department of Transportation (DOT) mandates testing for these five classes of drugs to ensure the safety and well-being of the traveling public and employees engaged in safety-sensitive positions within the transportation industry. Here's a breakdown of why each class of drug is included:

     • Marijuana:

       • Effects: Marijuana can impair motor coordination, judgment, and reaction times.
       • Relevance: Employees under the influence of marijuana can pose significant safety risks in transportation settings, potentially causing accidents due to delayed decision-making or misjudgment of situations.

     • Cocaine:

       • Effects: Cocaine is a stimulant that can lead to euphoria, increased energy, alertness, and sensitivity to stimuli. However, it can also lead to paranoia, unpredictability, and impaired judgment.
       • Relevance: The erratic behavior and altered judgment due to cocaine can be hazardous in safety-sensitive roles. Its short-lived effects can also lead to sudden crashes in energy, which can be problematic for tasks requiring consistent alertness.

     • Amphetamines (including methamphetamines):

       • Effects: These stimulant drugs can increase focus and energy in the short term but can also lead to agitation, paranoia, hallucinations, and dangerous risk-taking behavior.
       • Relevance: While some people misuse amphetamines to stay awake and alert, the potential side effects, including erratic behavior and poor decision-making, can compromise safety in transportation environments.

     • Opioids (like heroin, codeine, morphine, hydrocodone, hydromorphone, oxycodone and oxymorphone):

       • Effects: Opioids depress the central nervous system. They can lead to drowsiness, impaired cognitive function, slowed reaction times, and respiratory depression.
       • Relevance: The sedative effects of opioids are especially concerning in transportation sectors, where a lapse in attention or slowed reaction can have catastrophic consequences.

     • Phencyclidine (PCP):

       • Effects: PCP is a hallucinogenic drug that can lead to distorted perceptions of reality, hallucinations, and aggressive or violent behavior. It can also result in numbness, slurred speech, and a sense of detachment.
       • Relevance: The severe cognitive distortions and potential for violent behavior under the influence of PCP make it incredibly risky in any setting, especially in safety-sensitive roles.

7. Medical Review Officer (MRO) Involvement:

   • Once the laboratory completes testing, the results are sent to an MRO. The MRO reviews the results, ensuring that legal or prescribed drug use hasn't caused any positive results.
   • If a test is non-negative (positive), the MRO contacts the employee to discuss the result before reporting it to the employer, giving the employee a chance to provide any relevant medical information.

8. Record Keeping:

   • Employers must maintain records of their drug and alcohol testing program, including test results, for a period determined by DOT regulations.

9. Confidentiality:

   • Test results and related information should be kept confidential and only released to those who need it to perform their duties.

10. Employee Rights:

    • If an employee tests positive, they can request a retest of the split specimen (Bottle B) at a different SAMHSA-certified laboratory.

11. Return-to-duty Process:

    • If an employee has a verified positive test or refuses to test, they need to see a Substance Abuse Professional (SAP) and complete the return-to-duty process, which includes an evaluation, possibly education or treatment, a return-to-duty test, and follow-up tests.

By adhering to DOT drug testing requirements, employers reinforce the integrity and trustworthiness of the testing process, underscoring their dedication to safety in the workplace.

Test Types by DOT Agency

The DOT agencies name similar test types in their own rules:

• FMCSA: pre-employment drug testing (pre-employment alcohol testing is optional), post-accident, random, reasonable suspicion, return-to-duty, and follow-up testing (49 CFR 382.301 to 382.311).
• FAA: pre-employment, random, post-accident, reasonable cause, return to duty, and follow-up drug testing (14 CFR 120.109), with the same alcohol test types in 14 CFR 120.217.
• FTA: pre-employment drug testing (pre-employment alcohol testing is optional), reasonable suspicion, post-accident, random, return to duty, and follow-up testing (49 CFR 655.41 to 655.47).

FRA and PHMSA use their own terms, and FRA adds post-accident toxicological testing (49 CFR Part 219). Testing procedures for each agency follow 49 CFR Part 40.

In DOT drug and alcohol testing, the roles of urine Collectors, BATs (Breath Alcohol Technicians), and STTs (Screening Test Technicians) come with rigorous and methodical training requirements. These standards are set out in 49 C.F.R. § 40, ensuring that professionals in these roles are proficient in their tasks and well-versed in the regulatory framework surrounding them. This introductory training forms the cornerstone of their qualification and professional journey.

The Initial Training can be broadly viewed as a three-pronged approach, wherein each facet builds upon the last to provide a holistic foundation for the professionals involved.

• Basic Information Training:
  • Purpose: This stage is designed to instill an in-depth understanding of the regulatory backdrop. Before stepping into the practical elements of their roles, the technicians and collectors must be well-acquainted with the rules that govern them.
  • Content:
    • For Collectors: They delve into 49 C.F.R. Part 40, the DOT Urine Specimen Collection Procedures Guidelines, and the DOT agency regulations that apply to the employers they serve (49 C.F.R. 40.33(a)).
    • For STTs and BATs: Their focus centers around 49 C.F.R. Part 40 and the Current DOT Guidance. They also cover the approved alcohol testing devices listed by DOT (49 C.F.R. 40.229).
• Qualification Training:
  • Purpose: Moving beyond theory and into practice, this segment of the training zeroes in on the actual procedures related to testing or collection. It's where the rubber meets the road, and professionals get hands-on exposure to their future tasks.
  • Content:
    • For Collectors: They learn the nitty-gritty, from step-by-step collection processes to dealing with complex situations like "shy bladder" scenarios or potential tampering.
    • For STTs and BATs: Their training aligns with the DOT Model BAT or STT course, which not only elucidates the testing procedures but also covers the specific devices they'll employ in their roles.
• Initial Proficiency Demonstration:
  • Purpose: As the culmination of the training, this is where theory and practice meld. It's the final test of the technician's or collector's grasp of regulations and hands-on procedures.
  • Content:
    • Collectors and STTs must complete five consecutive error-free mock collections or mock tests (49 C.F.R. 40.33(c) and 40.213(c)).
    • BATs must complete seven consecutive error-free mock tests (49 C.F.R. 40.213(c)).

Each phase of the Initial Training is instrumental in ensuring that when a professional steps into their role, they do so with confidence, proficiency, and a robust understanding of the regulatory environment.

As the complexities of specimen collection and alcohol testing evolve, so must the expertise of those at the helm. The world of DOT Urine Specimen Collection and testing is not static; it's a dynamic field that witnesses continuous advancements in techniques, tools, and best practices. In this evolving context, the importance of Refresher Training becomes clear.

Every profession, irrespective of its nature, requires ongoing education to ensure that professionals remain at the forefront of their fields. In Collectors, BATs (Breath Alcohol Technicians), and STTs (Screening Test Technicians), this continuous learning isn't just a matter of staying updated—it's imperative for maintaining the integrity of the testing processes.

The significance of Refresher Training lies in several crucial areas:

• Ensuring Accuracy: Techniques, technologies, and procedures refine over time. Regularly updating skills ensures collectors and technicians work with the latest, most accurate methods.
• Upholding Regulatory Compliance: As regulations evolve, staying abreast of the changes ensures that professionals always work within the bounds of the law, minimizing legal risks.
• Enhancing Public Trust: For those subjected to these tests, knowing that the professionals handling their specimens or tests are continually upskilled enhances trust in the results' validity.
• Mitigating Errors: Regular retraining is a preventive measure against potential oversights or mistakes arising from outdated practices or knowledge gaps.

"Refresher Training" is used specifically to denote the mandatory training required every five years per 49 C.F.R. Part 40.33 and 49 C.F.R. § 40.213. The renewal process revisits the foundational elements of Qualification Training and Initial Proficiency Demonstrations. It's a testament to the commitment to ensuring the highest testing and collection procedures standards.

In conclusion, while initial training sets the foundation, the ongoing Refresher Training ensures the edifice of expertise remains sturdy and up-to-date. Proper and regular training isn't just a regulatory mandate—it's the bedrock of professionalism and excellence in the field.

What employers and TPAs should track

Under 49 CFR 40.33(e), a urine collector must complete refresher training no less frequently than every five years from the date the collector completed initial qualification training and the five error-free mocks. The refresher must meet the same qualification training and proficiency demonstration rules as the initial training, including five consecutive error-free mocks with a written attestation. Parallel five-year rules apply to oral fluid collectors (40.35(e)) and to BATs and STTs (40.213(e)). An annual association exam, such as an NDASA CPC renewal exam, does not replace that five-year refresher. When an employer or C/TPA reviews a collector's file, the date that starts the five-year clock is the date the collector finished the last full qualification-plus-mocks cycle, not the date of a vendor product course or an association exam.

What the refresher and error correction rules require

A DOT urine collector completes refresher training at least once in each five-year period, counted from the date the collector completed qualification training and the initial proficiency demonstration. Refresher training repeats the qualification training subjects and the proficiency demonstration of five consecutive error-free mock collections (49 CFR 40.33(e)). The five mock collections include two uneventful collections, one with an insufficient quantity of urine, one with a temperature out of range, and one in which the employee refuses to sign the CCF and initial the tamper-evident bottle seal (49 CFR 40.33(c)(1)). A collector whose mistake causes a test to be cancelled completes error correction training within 30 days of being notified of the error, including three consecutive error-free mock collections (49 CFR 40.33(f)).

DOT specimen collection and alcohol testing mistakes can have serious implications. They can compromise the accuracy of results, jeopardizing public safety, undermining system trust, and leading to legal ramifications. This underscores the critical nature of Error Correction Training.

The rationale behind Error Correction Training isn't just about addressing errors after they occur. It's about embedding a culture of continuous improvement, fostering accountability, and ensuring standards are consistently upheld. Here are some pivotal points to consider:

• Proactive Addressal of Mistakes: Rather than dismissing or overlooking errors, the system mandates a systematic and structured approach to address and rectify them. This ensures that mistakes become learning opportunities.

• Instilling Confidence: By ensuring that errors are promptly addressed and rectified, stakeholders—employers, employees, or regulatory bodies—can have greater confidence in the system's integrity.

• Mitigating Repeated Errors: Through Error Correction Training, collectors and technicians are equipped with the knowledge and skills to prevent the recurrence of the same mistakes in the future.

• Upholding Legal and Regulatory Standards: Given the legalities associated with drug and alcohol testing, ensuring that collectors and technicians are well-trained to avoid and rectify errors is paramount. This training reduces the risk of lawsuits and ensures compliance with the stipulations of various regulations.

When a "fatal flaw" is identified, it triggers a series of necessary corrective actions. The individual responsible for the error must undergo "Error Correction Training" within 30 days of being notified about the mistake. This specialized training focuses on where the mistake occurred and ensures that the individual can demonstrate proficiency in that area. It's about ensuring they don't just understand the error but are equipped to prevent its recurrence.

It's worth noting that not all errors necessitate this training. Only fatal flaws—those critical mistakes that can result in the cancellation of a test—trigger this requirement. The emphasis is on addressing those mistakes that can fundamentally compromise the testing process.

DOT specimen collection and alcohol testing, Error Correction Training is a testament to the system's commitment to excellence and accuracy. It acknowledges that while humans are fallible, systems can be designed to correct, learn, and improve.

Joe was recruited to assist in a DOT direct observation urine specimen collection by the collector, Sally. She told Joe that he was supposed to “watch the urine leave the patient’s male anatomy.” However, during the process, Bill, the employee was belligerent and difficult. When Bill and Joe were alone in the bathroom, Bill filled the cup to the line and handed the cup to Joe so he could pull his pants up. Later, Bill said that Joe and Sally didn’t follow protocol because the cup was supposed to be held by the donor the entire time. Did Joe and Sally breach protocol by holding the cup for the donor while still in the restroom?

For those unfamiliar with observed collections, this scenario is referencing the procedure outlined in 49 CFR Part 40.67(k) which states, “[a]s the observer but not the collector, you must not take the collection container from the employee, but you must observe the specimen as the employee takes it to the collector.” The protocol is that the observer, if not the collector, does not come into contact with the specimen directly.

Before getting to the answer to the question, it is important to address ways to help prevent this situation from occurring in the first place. If the donor was being belligerent in any other step of the process, the first step would be for the collector, Sally, to warn Bill, the donor, that ignoring instructions and being belligerent will be considered a refusal and that she will have to stop the test if he continues to maintain non-compliance. This warning is expressly discussed in 49 CFR Part 40.191(a)(8) wherein employees are deemed to have refused if they “[f]ail to cooperate with any part of the testing process (e.g., refuse to empty pockets when directed by the collector, behave in a confrontational way that disrupts the collection process, fail to wash hands after being directed to do so by the collector).” This was also explained in the July, 2006 Frequently Asked Questions update from ODAPC; they recommend “[w]hen the issue is a problem with refusing to following instructions – for example, refusing to empty pockets or refusing to wash hands – or if there is a confrontation, the collector should warn the employee of potential consequences of a failure to cooperate; and if practical, seek assistance from the DER or supervisor to ensure that the employee understands the ramifications.”

In addition, 40.191(a)(9) speaks directly to direct observation refusals indicating a refusal when employees, “fail to follow the observer’s instructions to raise your clothing above the waist, lower clothing, and underpants, and to turn around to permit the observer to determine if [they] have any type of prosthetic or other devices that could be used to interfere with the collection process.”

Following these recommendations would have put Bill, the employee, on notice of the possible refusal and the resulting consequences.

The second step would be for the collector to ensure that Joe, as the observer, was properly trained on the procedure and to ensure that nothing he did or didn’t do could interfere with the test. The facts indicate that Joe may not have been properly trained if all the collector told him to do was “watch the urine leave the patient’s male anatomy.” However, even if Joe were properly trained as discussed in this course, there is still a chance that the donor would have given him no choice but to grab the cup to avoid spilling it. Had there been a proper explanation to both Bill and Joe regarding the rules for a direct observation, then this kind of behavior could be immediately considered a refusal.

Under these facts, Bill would be right in stating that Sally and Joe didn’t follow protocol. The regulations clearly state that the observer must not take the collection container from the employee. The real question is, is the violation the kind that will result in a canceled test? There are no facts to suggest that the specimen was ever out of the donor’s sight or that the observer had an opportunity to adulterate the specimen. If there was, the issue would likely have been raised immediately. In this scenario, the facts only state that Bill made his allegations “later” meaning likely that the donor didn’t raise the issue until after the collection was complete and the results were reported.

The next question is: how much do ODAPC and the DOT care about this particular type of flaw? It isn’t listed under the problems that cause a drug test to be canceled in 49 CFR Part 40.199, 40.201, or 40.203. This leaves us to look for guidance under 49 CFR part 40.209(a) which states, “[a]s a collector . . . or other person administering the drug testing process, you must document any errors in the testing process of which you become aware, even if they are not considered problems that will cause a test to be cancelled as listed in this subpart. Decisions about the ultimate impact of these errors will be determined by other administrative or legal proceedings, subject to the limitations of paragraph (b) of this section.”

Since this particular error is not listed in any other section of the 49 CFR Part 40, it would be up to Joe and Sally to document the error. The donor may raise the error in a complaint to the DOT which may, or likely may not, initiate administrative proceedings against them. 49 CFR 40.209(b) goes on to limit the consequences for minor mistakes that don’t affect an employee’s right to a fair test, “[n]o person concerned with the testing process may declare a test canceled based on an error that does not have a significant adverse effect on the right of the employee to have a fair and accurate test.” If the specimen was not adulterated and had no opportunity to be switched, or broke chain of custody in any other way, then there could not have been a significant adverse effect on Bill’s right to a fair and accurate test.

Based on the facts provided, there was certainly an error in the process, but it didn’t affect the employee’s right to a fair and accurate test so the test could not be canceled as a result. However, there is still a possibility that the donor could report the issue to the DOT and that they could initiate administrative proceedings against Joe and Sally. Though the likelihood of an administrative proceeding is extremely slim.

Failing to complete reasonable suspicion training can lead to multiple consequences, including increased risks of oversight, non-compliance with regulations, potential legal ramifications, and jeopardized safety. It's essential to understand the importance and requirements of this training to ensure optimal outcomes in relevant scenarios.

Managers and supervisors are legally required to complete reasonable suspicion training if they are part of a DOT agency, and USCG regulations require the training to be completed[1]. However, as a busy employer, you may wonder why you must train your supervisors when they have many other responsibilities to complete. Unfortunately, the consequences of your staff forgoing this training are varied and vast. While the consequences start with law violations, they certainly do not end there.

Fines & Fees

If your supervisors are not trained in reasonable suspicion when it is necessary for them to be, you are in clear violation of the law and are subject to fines and fees until compliance is met[2]. These fines vary depending on the industry and the number of people that are found in violation of the law. However, these fines are inconsequential when compared to the more serious ramifications of under-trained supervisors.

Improper Documentation Can Lead to Lawsuits

Personal privacy is an employee’s right that is sensitive and easy to accidentally violate when proper training has not been implemented[3]. There are several ways in which a supervisor can cross the line when it comes to drug testing. When it comes down to word against word, the documentation that was recorded by the supervisor will be essential in protecting a business from litigation. When a supervisor orders a drug test, they must ensure that their documentation is written with attention to detail[4].

Details that must be included are:

Information on when and where the employee was observed. What was observed to raise suspicions? Observations can range from erratic behavior to twitchy movement, strange speech patterns, emotions, physical appearance, or simply inaction like sleeping or a lack of reaction to questions[5]. The secondary trained manager, supervisor, or company official was asked to assess the observation to determine if the suspicion is valid. The actions are taken to protect the employee and his or her surroundings, such as removing them from safety-sensitive areas.

The documentation must be specific, non-accusatory, and packed with observations that can be interpreted as reasonable suspicion. Supervisors are taught the specifics of documentation in reasonable suspicion training.

If your company is taken to court, lawyer fees and potential settlement costs can range in the hundreds of thousands, if not the millions.

Incorrectly Handling a Situation with an Employee Can Lead to Uncomfortable Situations

It can be very difficult to properly handle situations with employees, especially if a supervisor does not naturally have the skills to deal with the varied responses of an employee who may feel defensive. When an employee is approached about a situation or behavior that triggers a supervisor to feel suspicious, reactions can range from fear to sadness and aggression. Part of reasonable suspicion training involves giving a supervisor tools to deal with uncomfortable and tricky situations[6], making the situation more likely to be safe for all parties. If a supervisor does not have those tools, a situation can escalate when an employee becomes violent or otherwise difficult to deal with, which endangers both employee and supervisor.

Not Recognizing the Signs of Drug or Alcohol Abuse Can Result in Accidents

If an employee is good at hiding their drug or alcohol addiction, they may appear sound of mind to anyone who does not have a trained eye. Signs can vary from slight mood swings, changes in work attendance, unusual behavior when not directly in the presence of a supervisor, and other smaller, less visible signs, and a missed alcohol or drug impairment can cause accidents that result in injury or equipment damage and the death of the employee and others involved in an accident. Not only is this an avoidable tragedy, but it is also costly for all involved. An effortless way to ensure that your employees and supervisors are as safe as possible is to ensure that all managers in charge of employees complete the necessary two to three hours of training.

The "return-to-duty" process is a protocol to address situations where an employee breaches drug or alcohol testing guidelines. At its core, this process isn't just about compliance but is a holistic approach to nurturing workplace safety, fostering individual recovery, and maintaining organizational integrity.

For employees, the process provides a clear roadmap for those who may have inadvertently found themselves on the wrong side of substance regulation, and rather than facing abrupt termination, they are offered a structured pathway to rehabilitation. This approach underscores that people can and do make mistakes, but with the proper support and interventions, they can return to being productive and responsible team members.

Employers also find significant value in this process, and beyond the obvious benefit of maintaining a safe working environment, the process allows them to demonstrate a duty of care toward their workforce, and by following this protocol, they send a clear message about their commitment to employee well-being, while also shielding the organization from potential liabilities, and helps preserve the company's reputation as an entity that responsibly addresses substance-related challenges.

A Substance Abuse Professional (SAP) makes this process effective. SAP isn't just a gatekeeper, they are specialized experts with the skills and knowledge to navigate these sensitive circumstances effectively. Their role involves thoroughly assessing the employee in question, diving deep into understanding the gravity and nature of the substance challenge they face. After an analysis, the SAP formulates a tailored intervention strategy. This might entail specialized treatment programs targeting distinct dependencies, insightful counseling sessions to unearth and tackle root causes, or educational initiatives that shed light on substance abuse's broader implications and hazards. The pivotal role played by the Substance Abuse Professional (SAP) is central to the efficacy and compassion of this process.

To illustrate this, consider the following:

Example Scenario: a truck driver, Jane, tests positive for a banned substance during a random DOT test. Rather than immediate termination, she is referred to an SAP. The SAP evaluates Jane and recommends a 6-week counseling program. Upon completion, Jane undergoes a return-to-duty test, tests negative, and with ongoing follow-up tests, safely resumes her role. Through the SAP's guidance, Jane gets a chance at rehabilitation, and her employer ensures a safer work environment.

The actions taken in this process include, but are not limited to:

1. Violation Identification: Once a drug or alcohol violation is identified (either by a positive test result or refusal to test), the affected employee is immediately prohibited from performing any safety-sensitive duties.
2. SAP Referral: The employee is referred to a Substance Abuse Professional (SAP). An SAP is a credentialed expert responsible for evaluating the employee's substance use or abuse.
3. SAP Evaluation & Recommendations: After a thorough evaluation, the SAP provides a report outlining the required interventions. These can range from education to treatment or counseling.
4. Treatment & Education: The employee then undergoes the recommended interventions to address the root cause of the substance issue.
5. Return-to-Duty Test: Upon completion of the intervention, the employee must take a return-to-duty test and test negative before resuming safety-sensitive duties.
6. Follow-Up Testing: The SAP also prescribes a series of unannounced follow-up tests for the employee, ensuring continued compliance and safety.

Training Requirements: Proper training is indispensable for those involved in the return-to-duty process. This includes:

• For SAPs: They must hold one of the credentials listed in 49 CFR 40.281, complete qualification training on DOT regulations and the return-to-duty process, pass an exam given by a nationally recognized professional or training organization, and complete at least 12 hours of continuing education every three years.

• For Employers: Training helps employers understand the return-to-duty process, their responsibilities, and the importance of adhering to it. Designated Employer Representatives (DERs) should receive training on drug and alcohol testing requirements, recognizing violations, and coordinating with SAPs.

• For Employees: It is beneficial for employees, especially those in safety-sensitive positions, to undergo training about substance misuse, the implications of violations, and the return-to-duty process.

The return-to-duty process is not merely a regulatory obligation but a testament to an organization’s commitment to safety, rehabilitation, and the well-being of its workforce, and by understanding the integral role of SAPs and investing in the proper training, employers can foster a work environment that is both compassionate and compliant, which safeguards operational integrity and positions the organization to mitigate risk.

How the SAP process works under Part 40

A SAP evaluates each employee who has violated a DOT drug and alcohol regulation, recommends a course of education or treatment, and sends a written report with specific recommendations directly to the DER (49 CFR 40.293). Education can include self-help groups, community lectures and drug and alcohol education courses, and treatment can include in-patient, partial in-patient, out-patient counseling and aftercare (49 CFR 40.293(c) and (d)).

The return-to-duty test takes place only after the SAP determines that the employee has successfully complied with the prescribed education or treatment, and the employee needs a negative drug test result or an alcohol concentration below 0.02 before resuming safety-sensitive duties. The employer decides whether to return the employee to work, and a SAP does not make a fitness-for-duty determination unless a DOT agency rule requires it (49 CFR 40.305). SAP credentials include licensed physicians, licensed or certified social workers, psychologists, employee assistance professionals, and marriage and family therapists, and drug and alcohol counselors certified by an organization listed by ODAPC (49 CFR 40.281(a)). SAPs complete at least 12 professional development hours in each three-year period (49 CFR 40.281(d)).

DER Training stands for Designated Employer Representative Training. They are specialized training programs for individuals managing and overseeing their company's drug and alcohol testing programs. These representatives play a pivotal role in ensuring that workplaces comply with federal regulations related to drug and alcohol use, especially in safety-sensitive industries.

As part of the training, individuals learn about the various responsibilities of a DER, which include:

1. Coordinating Drug and Alcohol Testing: Ensuring all required drug and alcohol tests, whether random, post-accident, or based on reasonable suspicion, follow regulations.

2. Interpreting Testing Results: Upon receiving drug or alcohol test results, the DER determines further actions, especially positive results or test refusals.

3. Record-Keeping: Maintaining comprehensive records of all drug and alcohol tests, essential for compliance and potential audits or inspections.

4. Maintaining Confidentiality: A DER must ensure the confidentiality of all testing records and results, ensuring they're only shared with individuals with the authority to view them.

5. Communication: Act as the main point of contact between the company and service agents, such as testing laboratories and substance abuse professionals.

6. Staying Updated on Regulations: Keeping abreast of current regulations and guidelines to ensure the company's testing program remains compliant.

The primary objective of DER Training is to provide company representatives with the qualifications, skills, and knowledge needed to manage a company's drug and alcohol testing program, and beyond ensuring workplace safety, training also helps employers adhere to both non-DOT and DOT regulatory standards required by DOT agencies like FMCSA, FAA, FRA, FTA and PHMSA, and by the U.S. Coast Guard, which follows DOT drug testing procedures. The advantages of such training extend in several directions:

1. Risk Mitigation: Proper training ensures that companies follow standardized procedures and guidelines, drastically reducing the risk of discriminatory lawsuits. Training, uniform testing, and thorough documentation prove employers do not test based on biases or perceived unfairness.

2. Informed Decision-making: Trained DERs can make well-informed decisions regarding testing outcomes, test refusals, and subsequent measures, ensuring alignment with internal company policy and overarching federal regulations.

3. Beneficial for Non-DOT Employers: While the DOT mandates specific employers to possess qualified DERs, non-DOT employers benefit immensely from having a trained representative. Having a designated individual emphasizes the employer's commitment to maintaining a drug-free workplace. It also acts as a deterrent against drug and alcohol usage, fostering a safer and more productive work environment.

DER Training is a wise choice. It helps employers adhere to regulations, maintain a safe workplace, and reduce the risk of legal troubles. It signifies a firm commitment to proper drug and alcohol testing management — a goal every employer, DOT-regulated or not, should pursue.

What a DER should check before DOT testing starts

Before the first DOT collection of a testing cycle, a Designated Employer Representative (DER), or the program manager who supports the DER, should confirm:

• Collectors and alcohol technicians who will serve the employer have current qualification documentation available on request (49 CFR 40.33(g), 40.35(g), 40.213(g)).
• Collectors have been given the name and telephone number of the appropriate DER, and of the C/TPA where applicable, as required by 49 CFR 40.36.
• A service agent is not acting as the DER. 49 CFR 40.15(d) prohibits an employer from permitting a service agent to act as DER.
• Supervisors who make reasonable suspicion determinations have completed the mode-specific supervisor training hours that apply to that employer (for FMCSA, 60 minutes on alcohol misuse and 60 minutes on controlled substances under 49 CFR 382.603, and for FTA, the hours in 49 CFR 655.14(b)(2)).
• For FMCSA-regulated CDL drivers, Clearinghouse query and reporting steps are assigned to a registered user (employer or designated C/TPA), separate from collector qualification.

More detail on the DER role is in DER roles and responsibilities and what a Designated Employer Representative is. For how free or vendor collector modules differ from DOT qualification, see whether Quest Diagnostics' free collector training is enough for DOT qualification and free lab and vendor collector training versus DOT qualification.

DER courses by agency on Learn Laws

Learn Laws offers Designated Employer Representative courses for each DOT operating administration that has a course page, plus a non-DOT course for workplaces outside DOT testing. Organizations can enroll staff through a Training Manager account:

• FMCSA Designated Employer Representative Training
• FAA Designated Employer Representative Training
• FRA Designated Employer Representative Training
• PHMSA Designated Employer Representative Training
• USCG Designated Employer Representative Training
• Non-DOT Designated Employer Representative Training

Pick the course that matches the employer's DOT agency, or the non-DOT course when the workplace is outside DOT testing. These courses support DER duties under Part 40 and the related agency rules. This FAQ does not state that any agency requires one specific vendor course.

The Designated Employer Representative, often referred to as DER, is pivotal in maintaining a workplace that is both safe and adheres to regulations. Their role covers a broad spectrum of duties, each vital to the smooth operation of drug and alcohol testing programs:

1. Overseeing Drug and Alcohol Testing: The DER is not just responsible for ensuring drug and alcohol tests are conducted. They must also verify that these tests are carried out in strict accordance with the set standards and procedures. This means scheduling tests, ensuring proper collection methods are followed, and verifying the integrity of the testing process.

2. Making Decisions on Testing Results: The DER doesn't just passively receive results. If an employee produces a positive result or refuses a test, the DER must determine the next course of action. This can range from counseling, disciplinary actions, or even termination, all in line with the company's internal policies and federal guidelines.

3. Managing Records: Record-keeping isn't just about filing away results. It's about ensuring these records are organized, accessible, and complete. This record-keeping is essential for compliance and as a safeguard during potential audits, inspections, or legal proceedings.

4. Ensuring Confidentiality: With sensitive information at their fingertips, a DER must be the epitome of discretion. They must ensure test results and related records are kept confidential and shared only with those who have a legitimate need to know. This prevents potential misuse of information and protects employees' rights.

5. Liaising with Service Agents: Communication is key. The DER acts as a bridge between the company and external entities involved in testing. This can include labs that analyze samples, substance abuse professionals providing counseling, and other service agents facilitating the testing process.

6. Staying Updated: The world of regulations is ever-evolving. A DER must be proactive in staying informed about changes in federal guidelines, industry best practices, and emerging trends. This ensures the company's testing program remains both effective and compliant.

A DER serves as both guardian and guide, ensuring the organization navigates the complexities of drug and alcohol testing with precision and integrity.

The role of the Designated Employer Representative (DER) is not just a formality but a vital component in modern workplaces for several compelling reasons:

1. Safety First: At the heart of the DER's responsibilities is ensuring that workplaces are free from the influence of drugs and alcohol. This isn't just about following rules; it's about helping every employee, from the front desk to the factory floor, work in an environment where risks related to substance abuse are minimized. When employees are sober and alert, it leads to fewer accidents, better decision-making, and an overall safer work environment.

2. Staying Within the Law: The federal government, understanding the importance of safety, has rolled out specific regulations regarding drug and alcohol testing. This is particularly stringent in industries with higher stakes due to the inherent dangers, such as transportation, heavy machinery operation, and healthcare. DERs ensure that companies respect these rules and adhere to them rigorously, which helps employers avoid legal pitfalls and hefty fines and prevents potential lawsuits or sanctions.

3. Consistency Across the Board: Anyone can claim to run a drug and alcohol test, but without a standardized approach, there's a risk of discrepancies, biases, or mismanagement. DERs, with their training and expertise, ensure that every test is conducted the same way every time. This uniform approach means that all employees, regardless of rank or role, are tested under the same criteria, ensuring fairness and eliminating potential claims of discrimination or favoritism.

In simple terms, think of a DER as a trusted guide for businesses, helping them smoothly handle drug and alcohol testing while keeping the workplace safe, fair, and following the rules.

Drug and alcohol testing began to gain prominence in various contexts, including workplaces, sports, and law enforcement, primarily in the latter half of the 20th century. Here's a brief overview of the history:

• Workplace Testing: In the United States, workplace drug testing became more widespread in the 1980s. This was partly in response to safety concerns and partly due to the War on Drugs initiated by the Reagan administration. The Drug-Free Workplace Act of 1988 was a significant milestone, requiring some federal contractors and all federal grantees to agree to provide drug-free workplaces as a precondition for receiving a contract or grant from a federal agency.
• Sports: Drug testing in sports has a slightly earlier history, mainly to prevent performance enhancement through illicit means. The International Olympic Committee (IOC) first introduced drug testing at the 1968 Winter Olympics in Grenoble, France. This was in response to concerns about the use of performance-enhancing drugs that could give athletes an unfair advantage and pose health risks.
• Law Enforcement: In the context of law enforcement, particularly in the United States, drug testing became a tool for monitoring and enforcing drug-related offenses. It has been used in various capacities, such as testing individuals on probation or parole, as well as in investigations of drug-related crimes.
• Alcohol Testing: Alcohol testing, particularly in the context of driving under the influence (DUI), has been around since the early 20th century. The development of the Breathalyzer by Robert Borkenstein in the 1950s represented a significant advancement in law enforcement's ability to test drivers for intoxication.

Qualification training in drug and alcohol testing for both DOT and non-DOT testing is essential to ensure accuracy and reliability in test results, compliance with legal requirements, and the safety of individuals in various environments and provides ethical considerations, such as respecting privacy and maintaining confidentiality, which are vital in upholding the integrity and fairness of the testing process that ensures the rights of those being tested and the interests of entities conducting the tests. 

RST Certification, an acronym for Reasonable Suspicion Training Certificate, training plays a critical role within the Department of Transportation's (DOT) regulatory framework and is a mandatory requirement for supervisors and managers across all DOT-regulated industries.

Its primary objective is to provide supervisors with the skills and knowledge necessary to promptly recognize indicators of drug or alcohol misuse among employees in safety-sensitive positions. This capability is pivotal in facilitating timely intervention and maintaining a secure workplace environment and is mandatory for supervisors and managers.

Under FMCSA, FTA, PHMSA and FAA rules, RST certification training covers at least 60 minutes for making drug testing reasonable cause determinations and at least 60 minutes for assessing reasonable suspicion for alcohol testing, for a total of at least 2 hours. FRA sets required topics without a minimum length, and USCG requires at least 60 minutes. This training focuses on specific, real-time, well-articulated observations encompassing appearance, speech, behavior, and body odor.

Supervisors of employees subject to DOT drug and alcohol testing must complete Reasonable Suspicion Training as a part of their ongoing commitment to safety and compliance within their respective transportation sectors. Both employers and employees within DOT-regulated industries must stay updated on the latest training requirements and guidelines specific to their roles and modes of transportation to ensure full compliance with DOT regulations.

While DOT regulations mandate training for supervisors overseeing DOT-regulated activities, it's important to recognize that earning an RST training certificate in non-DOT industries is equally valuable, and although not federally mandated, enrolling supervisors in such training equips them with the essential skills and tools to identify early signs of substance misuse. This proactive approach enhances workplace safety, reduces potential liability risks, bolsters productivity, and cultivates a culture of responsibility and compliance, making it a prudent investment for employers in various sectors.

The Department of Transportation (DOT) in the United States regulates various industries and modes of transportation to ensure safety, compliance, and efficient transportation systems. The DOT oversees several agencies, each responsible for specific sectors. Here are some of the industries and modes of transportation regulated by the DOT:

• Aviation: The Federal Aviation Administration (FAA), a branch of the DOT, regulates civil aviation, including commercial and private aircraft, airports, and air traffic control.
• Highways and Motor Carriers: The Federal Motor Carrier Safety Administration (FMCSA) regulates commercial motor vehicles, trucking companies, and bus transportation. This includes regulations for truck drivers, motor carriers, and safety standards.
• Railroad: The Federal Railroad Administration (FRA) oversees safety and operations in the railroad industry, including freight and passenger rail.
• Public Transportation: The Federal Transit Administration (FTA) focuses on public transportation systems, such as buses, subways, light rail, and commuter rail systems.
• Maritime: The Maritime Administration (MARAD) deals with the maritime industry, including shipping, ports, and shipbuilding.
• Pipeline: The Pipeline and Hazardous Materials Safety Administration (PHMSA) regulates the transportation of hazardous materials via pipelines and other means.

RST Certification is crucial in DOT-regulated industries for maintaining safety and compliance. It's equally beneficial in non-DOT sectors, enhancing safety, reducing liability, and promoting responsibility. The DOT oversees a wide range of industries to ensure safety and efficiency.

DOT stands for The Department of Transportation, established by an act of Congress on October 15, 1966.[1] It began operations on April 1, 1967. The creation of the DOT responded to the increasing complexity of transportation needs in the mid-20th century, which required a more coordinated and organized approach. It brought together various transportation agencies under one umbrella to ensure better management and regulation of the nation's transportation systems.

Functions and Regulation

The Department of Transportation (DOT) regulates various transportation industries through specific regulations and statutes. Each sector is governed by distinct parts of the Code of Federal Regulations (CFR), which detail the safety, operations, and compliance requirements. Here's a breakdown by industry:

• Federal Aviation Administration (FAA): Regulations are primarily found under Title 14 of the CFR, known as the Federal Aviation Regulations (FARs).
• Federal Motor Carrier Safety Administration (FMCSA): Regulations are in Title 49 of the CFR, Parts 300-399, which include commercial vehicle operations, safety standards, and driver qualifications.
• Federal Railroad Administration (FRA): The rail industry is regulated under Title 49, Parts 200-299 of the CFR. These regulations cover railroad safety, track standards, and operational practices.
• Federal Transit Administration (FTA): Public transit regulations are in Title 49, Parts 600-699 of the CFR, focusing on public transportation safety and funding.
• Maritime Administration (MARAD): MARAD is the DOT agency for the maritime industry. The U.S. Coast Guard (USCG) is part of the Department of Homeland Security, not DOT. Its maritime safety and security rules are in Titles 33 and 46 of the CFR, and it follows DOT procedures for drug testing (49 CFR 40.3).
• Pipeline and Hazardous Materials Safety Administration (PHMSA): Regulations for pipelines and hazardous materials transportation are in Title 49, Parts 100-199 of the CFR.

The DOT has the authority to implement and enforce transportation safety standards and regulations. These regulations are designed to ensure the safety and well-being of the public and protect the environment from transportation-related hazards. Each part of the CFR contains detailed regulations that address specific aspects of safety, training, operations, and maintenance within their respective areas. They are essential for ensuring the safety and efficiency of the U.S. transportation system.

Drug and Alcohol Testing

One central aspect of the DOT's regulatory responsibilities is ensuring that safety-sensitive transportation employees in aviation, trucking, railroads, mass transit, pipelines, and other transportation sectors are drug and alcohol-free. This is where DOT drug and alcohol testing regulations come into play.

DOT Reasonable Suspicion Training

The Department of Transportation (DOT) mandates that supervisors receive Reasonable Suspicion Training to identify potential drug and alcohol use among safety-sensitive employees. This training equips supervisors with the skills to recognize behavioral and physical signs of substance abuse, ensuring they can make informed decisions about initiating testing when necessary. Compliance with this requirement is crucial for maintaining safety in the transportation sector, as it prevents impaired individuals from performing safety-sensitive duties. The training encompasses the legal and procedural aspects of the DOT's drug and alcohol testing program, emphasizing the importance of accurate documentation, confidentiality, and appropriate follow-up actions.

DOT Urine Specimen Collection

The DOT requires urine specimen collection for drug testing. This is one of the most widely used testing methods and must be conducted under highly controlled and standardized conditions to ensure the integrity of the specimen and the accuracy of the test results. The DOT has specific procedures and protocols for collecting, handling, and analyzing these urine samples.

DOT Breath Alcohol Testing

In addition to DOT Urine testing, the DOT mandates breath alcohol testing for safety-sensitive employees. This testing uses breathalyzers to measure alcohol concentration in an individual's breath, providing immediate results. The goal here is to prevent individuals who have consumed alcohol from performing safety-sensitive functions, thereby protecting public safety.

DOT Oral Fluid Testing

DOT has also authorized oral fluid testing as a method for drug testing, in a rule that took effect June 1, 2023. DOT oral fluid tests cannot begin until HHS certifies oral fluid laboratories, and the September 30, 2026 HHS list shows none. This relatively new approach involves analyzing a saliva sample for the presence of drugs. Oral fluid testing is considered less invasive and can be more effective in detecting recent drug use.

Summary

The Department of Transportation is critical in ensuring the nation's transportation systems are safe, efficient, and environmentally sound. Its regulatory oversight extends across various transportation modes, and its drug and alcohol testing regulations are vital for maintaining safety in all areas it oversees. This ensures that the people and goods across the United States do so safely and reliably.

Becoming a drug test technician involves understanding several important elements, including the nature of drug testing, specific training requirements, testing modalities, and the consequences of inadequate training. Let's break down each of these components:

Drug Testing

Drug testing is a procedure that detects the presence of illicit drugs, controlled substances, or the misuse of prescription medication in an individual's system. It's commonly used in various settings, including employment, sports, rehabilitation, and law enforcement, to ensure safety, compliance with regulations, and a drug-free environment. Drug testing can be conducted using urine, breath, oral fluid, hair, or sweat samples.

There are two main tests, DOT and non-DOT. DOT drug testing follows strict federal guidelines for safety-sensitive positions, while non-DOT testing is more flexible, tailored to employer policies, and not governed by federal regulations.

Breath Alcohol Testing

Alcohol testing measures an individual's intoxication level through various methods, notably the Breathalyzer test, which is prevalent in law enforcement and workplace safety, especially under DOT regulations. This non-invasive, quick, and accurate method involves blowing into a device to measure breath alcohol content, ensuring safety, compliance with alcohol policies, and support for those with alcohol use challenges.

DOT breath alcohol testing adheres to federal regulations with specific procedures and thresholds for safety-sensitive employees, whereas non-DOT testing can vary according to employer policies without federal constraints.

Training Requirements (49 CFR Part 40)

Under the U.S. Department of Transportation (DOT) regulations, specifically 49 CFR Part 40, individuals who perform drug and alcohol tests must undergo specific training. Training typically covers:

Qualification Training

Qualification training for drug test technicians, particularly those operating under the 49 CFR Part 40 guidelines, is an extensive educational program designed to ensure that individuals are well-versed in the regulatory, procedural, and ethical aspects of conducting drug and alcohol tests in safety-sensitive transportation industries. This training encompasses a wide array of critical topics, aiming to provide an understanding and skill set necessary for the proper execution of testing procedures.

Mock Collections

Mock collections are practical simulations providing hands-on experience conducting drug and alcohol tests. These exercises are crucial for ensuring that a technician is competent in performing tests under different circumstances, including handling uncooperative test subjects, dealing with specimen tampering, and ensuring the integrity and confidentiality of the test results.

Collection Process

A significant portion of the training is dedicated to the collection process itself. This includes detailed instructions on adequately collecting urine, breath, and oral fluid specimens while maintaining the sample's integrity and ensuring the privacy and dignity of the tested individual. Technicians are taught specific procedures to avoid contamination or tampering of specimens, accurate labeling, and secure transportation of samples to the laboratory for analysis.

Handling of Specimens

Proper specimen handling protocols are crucial to prevent contamination or loss of integrity, which could compromise test results. Training covers the correct storage conditions, documentation, and chain of custody requirements to ensure specimens are accurately tracked from collection to analysis. Technicians learn how to handle unexpected situations, such as insufficient sample volume or evidence of tampering.

Drug and Alcohol Testing Training Courses

• DOT Urine Collection: Used for DOT-regulated drug testing, it involves collecting a urine sample that tests for marijuana, cocaine, amphetamines, opioids and phencyclidine (PCP) (49 CFR 40.85).
• Non-DOT Urine Collection: This method is similar to DOT urine collection but is used in non-regulated environments. The substances tested can vary based on employer requirements.
• DOT Breath Alcohol Technician (BAT): A BAT uses a breathalyzer to measure alcohol concentration in an individual's breath, indicating current levels of intoxication. This method is used for DOT-regulated alcohol testing.
• Oral Fluid: This modality tests for the presence of drugs in saliva. It is less invasive and can detect recent drug use. It is used in non-DOT testing now and is authorized for DOT testing once HHS certifies oral fluid laboratories.
• DOT Oral Fluid: Authorized for DOT testing since June 1, 2023, this modality tests for the same substances as urine testing but uses oral fluid samples. DOT oral fluid tests cannot begin until HHS certifies oral fluid laboratories, and none were certified as of September 30, 2026.
• Non-DOT Oral Fluid: Used in non-regulated environments, allowing for flexibility in the substances tested and quicker detection of recent drug use.

Risks of Inadequate Training

Through training, technicians become proficient in the procedures for collecting, handling, and analyzing specimens. This proficiency minimizes the risk of errors that could lead to false positives or negatives, which could unjustly affect an individual's employment, legal standing, or health care. Training in regulatory standards ensures that every step of the process, from the initial collection to the final analysis, is executed with precision, thereby upholding the integrity of the results.

Inadequate training can lead to significant consequences, including, but not limited to:

• Invalid Test Results: Incorrect collection procedures can compromise test integrity, producing false positive or negative results.
• Legal Challenges: Errors in the testing process can result in legal action from unfairly treated or penalized individuals based on flawed test results.
• Reputation Damage: Organizations that conduct improper testing may face reputational damage, undermining trust among employees, customers, and regulatory bodies.
• Safety Risks: In safety-sensitive industries, inaccurate testing can result in unaddressed substance misuse, posing serious safety risks to individuals and the public.

The role of training and strict adherence to regulatory standards in the realm of drug testing cannot be overstated. These components ensure that each drug testing process is carried out with the utmost accuracy, integrity, and ethical consideration, safeguarding against the many risks of inadequate training. By investing in the thorough preparation of technicians and rigorously following established guidelines, organizations can uphold public safety, maintain their credibility, and protect the rights and welfare of individuals.

A specimen collector conducts and performs collections for drug tests and ensures all procedures adhere to specific state and federal regulations. Their responsibilities include collecting urine, blood, or other samples from employees, properly labeling and documenting the samples, and maintaining a strict chain of custody to prevent tampering or contamination.

DOT (Department of Transportation) and non-DOT drug tests differ primarily in their legal requirements and the substances they screen for. DOT tests are federally mandated and follow strict guidelines set by the Department of Transportation, applying to safety-sensitive transportation employees in aviation, trucking, railroads, mass transit, and other sectors. These tests are highly standardized and include checks for specific drugs as defined by DOT regulations. Non-DOT tests, on the other hand, are not federally regulated and can be customized by employers to suit their specific workplace policies. This means they can vary in the substances tested and the procedures used, depending on the employer's requirements and the local laws.

The U.S. Bureau of Labor Statistics (BLS) does not publish wage data for drug test specimen collectors as a separate occupation. The closest BLS occupation is Phlebotomists (SOC 31-9097). In May 2025, the median annual wage for phlebotomists was $45,230. The lowest 10 percent earned less than $35,780, and the highest 10 percent earned more than $58,780 (BLS, Occupational Employment and Wage Statistics, May 2025). Pay varies by location and employer.

More detail is in How Much Do DOT Specimen Collectors Make?

Proper qualification and training are essential for a specimen collector. This training ensures they are competent in handling sensitive materials and understand the legal implications of their work. It also helps them perform their duties accurately and ethically, ensuring that the testing process is reliable and respecting all individuals' privacy and rights. The risks of not being adequately trained as a specimen collector can have significant consequences, both for the individual being tested and the organization conducting the tests.

Here are some key risks associated with inadequate training:

• Contamination of Samples: Improper handling of specimens can lead to contamination, which might result in inaccurate test results. This can lead to wrongful accusations or misdiagnosis.
• Violation of Privacy and Legal Standards: A lack of understanding of legal and privacy issues can result in breaches of confidentiality and potential legal repercussions for the organization.
• Inefficient Collection Procedures: Without proper training, collectors might use incorrect methods, leading to delays in testing and potential degradation of samples, which affects the reliability of results.
• Loss of Credibility and Trust: Errors due to insufficient training can undermine the credibility of the testing process and erode trust among employees or patients, impacting the overall environment of the workplace or healthcare setting.
• Potential Legal Liabilities: Mistakes in the collection, handling, and processing of samples can expose the organization to legal challenges, especially if the outcomes of testing lead to significant decisions such as termination of employment or legal actions.

Ensuring that specimen collectors are thoroughly trained is crucial for maintaining the testing process's integrity and safeguarding individuals' rights and health. Specimen collectors are typically hired by various organizations where drug testing is required. These include, but are not limited to:

• Medical Laboratories: These facilities are major employers of specimen collectors, where they handle and process a wide range of biological samples for testing and analysis.
• Hospitals and Clinics: In healthcare settings, specimen collectors may work to gather samples for drug screenings, medical testing, or disease diagnosis.
• Corporate and Private Businesses: Companies that implement drug-free workplace policies often hire specimen collectors to conduct routine drug testing of their employees.
• Government Agencies: Various government jobs, especially those involving public safety or sensitive positions, require regular drug testing, for which specimen collectors are employed.
• Drug Rehabilitation Centers: These centers need specimen collectors to monitor the substances in patients' systems as part of treatment programs.

These employers rely on specimen collectors to ensure the integrity and accuracy of urine and oral fluid collections, which is crucial for the reliability of test results and adherence to legal and health standards.

DOT Collector Qualification, often called certification, is a qualification that proves someone has met the necessary training to conduct DOT-regulated drug tests and is required to undergo refresher training every five years to ensure they remain current with evolving regulations and procedures.

DOT-qualified collectors must follow strict federal guidelines necessary for ensuring the safety of those in transportation-related jobs. For example, a DOT collector would be responsible for checking identification, providing the specimen is collected in a tamper-evident container, and observing the process, if required, to prevent any possibility of tampering.

It is also important to note that DOT and non-DOT testing differ primarily in their regulatory frameworks and applications. DOT testing is governed by strict federal guidelines designed for safety-sensitive transportation roles and includes specific procedures and drugs that must be tested, while non-DOT testing is less regulated and can be customized according to an employer's policies, potentially including a broader or different set of substances.

Training for DOT qualification is required under the 49 CFR Part 40 to ensure collectors fully understand and can apply these protocols effectively. Proper training minimizes risks such as sample contamination, violations of testing procedures, and potential legal challenges that could arise from incorrect handling or documentation errors. Being adequately qualified as a DOT collector maintains the integrity of the testing process and upholds safety standards critical to public and workplace safety.

Understanding that the term 'qualification' rather than 'certification' underscores the requirement for continuous learning and adherence to strict protocols highlights the seriousness and importance of the DOT collector's role in maintaining safety and compliance in the transportation industry.

Association certificates and DOT qualification

Industry groups such as the National Drug & Alcohol Screening Association (NDASA) offer professional collector designations, including an annual Certified Professional Collector (CPC) exam. Those programs can document professional standing. They are separate from DOT collector qualification under 49 CFR 40.33. NDASA states that collectors must complete full collector training and mock collections every five years to remain qualified for DOT collections, and that the annual CPC exam alone does not meet that requirement. Employers and C/TPAs who see an association certificate on a resume should still request the Part 40 documentation described in proof of training: qualification training, five error-free mocks with a written attestation, and the current five-year refresher date. Free vendor modules are also not a substitute for that record. See whether Quest Diagnostics' free collector training is enough for DOT qualification.

An observed collection is a specific drug test procedure where a trained observer directly watches the donor's urine sample. This step helps prevent tampering or substitution of the urine specimen. The observer protects the sample's integrity by following these steps:

• Instructing the donor to raise clothing above the waist, lower clothing and underpants, and turn around to show there is no prosthetic or other device (49 CFR 40.67).
• Watching the urine go from the donor's body into the collection container without losing sight of the container.
• Confirming the donor does not turn away or conceal the collection process.
• Observed collections are typically required when there is a suspicion of specimen tampering, following a prior invalid test result, or as part of a return-to-duty or follow-up testing program. The observer must be the same sex as the donor (49 CFR 40.67), and the procedures must respect the donor's privacy while maintaining the collection's integrity.

Proper training in drug and alcohol testing helps collectors understand when and how to conduct observed collections correctly, maintaining the integrity of the testing process and complying with regulatory requirements. This knowledge helps avoid errors and helps confirm that procedures are followed, protecting both the donor's rights and the accuracy of the test results.

How did the 2026 DOT rule change observed collections?

A DOT rule published May 11, 2026, and effective June 10, 2026, changed how observed collections work while oral fluid testing is not yet available (91 FR 25507). The 2023 rule called for an oral fluid test when an observer could not be easily provided and in certain other situations. Because there are no HHS-certified oral fluid laboratories, that requirement could not be met, so the 2026 rule directs a directly observed urine collection in those cases instead (91 FR 25507).

Under the amended 49 CFR 40.67, when oral fluid testing is not yet available and no same-sex observer is present at the collection site, the collector contacts the Designated Employer Representative (DER). The DER either arranges for a same-sex observer to be present at the time of the collection or sends the employee to a collection site acceptable to the employer for a directly observed urine collection. The rule also replaced the word "gender" with "sex" in 49 CFR 40.67, 40.69, and 40.145 (91 FR 25507).

Once oral fluid testing is available and a same-sex observer cannot be found, the collector follows any employer standing order that allows oral fluid testing in that situation. Without a standing order, the collector contacts the DER, who directs an oral fluid test at the site if the site can conduct one or sends the employee to an acceptable site for the oral fluid test. Availability means at least two HHS-certified oral fluid laboratories, a qualified oral fluid collector, and a conforming collection device. After HHS gives notice of the second certified laboratory, an 18-month grace period begins, and an employer that is ready to use oral fluid testing during that period must do so (49 CFR 40.67).

As of the HHS list published September 30, 2026, no laboratories were certified to test oral fluid specimens (91 FR 61854).

Official Sources

• 91 FR 25507 (Federal Register)
• 49 CFR 40.67 (eCFR)
• 91 FR 61854 (Federal Register)

The contact details provided are for HHS-certified laboratories and Instrumented Initial Testing Facilities (IITFs) that meet the minimum standards for conducting drug and specimen validity tests on urine and oral fluid specimens. While these details can be used to contact the labs, it's essential to verify with each lab if these are the correct contacts for setting up a lab account to submit samples. View the SAMHSA Certified Lab List or contact SAMHSA directly by email at workplace@samhsa.hhs.gov or by phone at 240-276-2600.

To ensure accuracy, please follow these steps:

• Contact the lab directly using the provided phone numbers or addresses.
• Inquire specifically about setting up a lab account to submit samples.
• Verify if there are any additional requirements or specific contacts within the lab for account setup and sample submission.
• Always check the most recent updates or contact the labs to confirm the current and correct certifications for your specific needs.

The regularly updated list of certified Labs can also be found here.

Yes, in part. On April 28, 2026, the Drug Enforcement Administration (DEA) moved two groups of marijuana products from Schedule I to Schedule III of the Controlled Substances Act: FDA-approved drug products that contain marijuana, and marijuana covered by a state medical marijuana license.

All other marijuana, including adult-use (recreational) marijuana, remains in Schedule I. A broader hearing on moving all marijuana to Schedule III began on June 29, 2026, and was paused on September 29, 2026.

For decades, the federal stance on marijuana remained relatively fixed, which makes the 2026 order a notable shift.

Historical Context: How We Got Here

The Controlled Substances Act and Schedule I Classification

In 1970, Congress passed the Controlled Substances Act (CSA), establishing a framework for regulating drugs based on their medical utility and abuse potential. Marijuana was classified as a Schedule I substance, the most restrictive category, alongside heroin and LSD. This designation indicated that marijuana was considered to have:

• A high potential for abuse,
• No accepted medical use in treatment, and
• A lack of accepted safety for use under medical supervision.

This classification has remained controversial for over 50 years, as research has emerged suggesting the therapeutic benefits of cannabis in treating conditions such as chronic pain, epilepsy, and nausea from chemotherapy.

The Fight for Rescheduling

Since the 1970s, advocates have pushed for marijuana to be removed or rescheduled within the CSA. Key milestones include:

• 1972 NORML Petition: The National Organization for the Reform of Marijuana Laws (NORML) filed a petition to reschedule marijuana. After years of litigation, the DEA denied the petition in 1992, finding that marijuana lacked a "currently accepted medical use." A federal appeals court upheld the denial in 1994.
• 1996 State Legalization Efforts: California became the first state to legalize medical marijuana with Proposition 215. Over the next two decades, dozens of states followed suit, creating a patchwork of state laws inconsistent with federal policy.
• 2002 Coalition for Rescheduling Cannabis Petition: This petition brought renewed attention to marijuana's status, but the DEA denied it in 2011, finding no currently accepted medical use. The DEA denied two more rescheduling petitions in 2016.
• Public and Scientific Shifts: By the late 2010s, public opinion had dramatically shifted. A Pew Research Center survey in 2021 found that 91% of Americans supported either medical or complete legalization of marijuana. Simultaneously, research began to challenge earlier views about marijuana and its medical efficacy.

In October 2022, President Biden called on the Secretary of Health and Human Services (HHS) and the Attorney General to review marijuana. This marked a significant turning point, as the HHS subsequently recommended rescheduling marijuana to Schedule III in 2023. This recommendation acknowledged that:

• Marijuana has an accepted medical use,
• Its potential for abuse is lower than Schedule I or II drugs, and
• Its abuse may lead to moderate or low physical dependence.

In May 2024, the Department of Justice proposed a rule to move marijuana to Schedule III.

What Changed in 2025 and 2026

The hearing planned for early 2025 did not produce a decision. As of December 2025, the 2024 proposed rule was still awaiting an administrative law hearing.

On December 18, 2025, Executive Order 14370 directed the Attorney General to complete the rulemaking to move marijuana to Schedule III as quickly as federal law allows.

On April 28, 2026, the DEA issued a final order (91 FR 22714), effective that day. It placed FDA-approved marijuana products and marijuana covered by a state medical marijuana license in Schedule III (21 CFR 1308.13(g)).

An expedited hearing on moving all marijuana to Schedule III ran from June 29 through July 15, 2026. On September 29, 2026, the DEA’s administrative law judge stayed the case while considering a request to add a new report to the record. As of October 20, 2026, the stay remained in place and no final decision on broader rescheduling had been issued.

Rescheduling marijuana has significant implications for professionals in workplace compliance, healthcare, and law enforcement. Continuing education is essential for adapting to these changes and ensuring the effective implementation of policies.

Implications for Employers

With part of the change already in effect, employers and professionals in fields related to workplace safety and regulatory compliance may need to reevaluate their current policies. For example:

• DOT Testing: DOT drug testing rules did not change. Marijuana is still on the DOT test panel (49 CFR 40.82). On May 15, 2026, DOT issued an official Part 40 Q&A on what a Medical Review Officer may not consider when verifying a marijuana positive. See this FAQ on MRO review.
• Policy Revisions: Employers rely on federal schedules to guide their internal substance policies. Altering marijuana policies may prompt employers to update their testing protocols, clarify permissible use under medical guidelines, and ensure adherence to state and federal regulations.
• Interpreting Conflicting Standards: Many states have already introduced varying degrees of legalized marijuana use, creating a complex compliance environment. If federal rules shift, organizations may need to reconcile previously conflicting positions, ensuring that workplace policies align with evolving requirements.
• Staying Informed: As studies on marijuana and applications continue, professionals engaged in compliance, human resources, and legal guidance must remain knowledgeable about changes. A comprehensive understanding will help them address new challenges as the regulatory landscape evolves.
• Professional Education: Marijuana's rescheduling underscores the need for ongoing education for legal and compliance professionals. Staying updated on regulations, science, and policies ensures lawful, informed workplace practices. Regular training and certifications help professionals who maintain employ drug-free workplaces or perform drug testing adapt and provide practical guidance in a rapidly evolving regulatory landscape.

Does rescheduling change DOT drug testing?

Rescheduling does not by itself change DOT drug testing. Marijuana metabolites are on the DOT urine panel in 49 CFR 40.85, and the DOT panel is set in 49 CFR Part 40. Most marijuana remains in Schedule I (21 CFR 1308.11). Marijuana in an FDA-approved drug product or subject to a state medical marijuana license has been in Schedule III since April 28, 2026 (21 CFR 1308.13(g)).

What Lies Ahead?

The remaining question is whether all marijuana will move to Schedule III. That depends on the outcome of the paused hearing and a final DEA order. In each scenario, the implications extend beyond law enforcement. They touch upon how employers manage personnel, how medical professionals advise patients, and how the public interprets marijuana use's benefits and potential drawbacks.

In the coming months, stakeholders, from corporate counsel to the human resources team, would be well advised to monitor these developments. As events unfold, the ability to adapt policies and practices to reflect updated federal guidelines will prove essential. The 2026 order marks a turning point and serves as a reminder that what was once considered settled law may now be subject to reconsideration in an evolving regulatory climate.

Many people wonder how to become a “certified” drug screen collector, but the correct industry term is a qualified collector. It’s important to note that neither the Department of Transportation (DOT) nor its sub-agencies offer direct certification or qualification.

Those interested in becoming qualified collectors must receive training from an instructor who has completed a recognized train-the-trainer program. Be cautious of providers claiming to offer “certification” without meeting these standards, as such programs often provide only a certificate of completion rather than a legitimate qualification.

To achieve qualified status, an individual must complete initial proficiency and mock collections. Initial proficiency focuses on learning essential procedures, including proper specimen handling and accurate chain-of-custody documentation. Mock collections, also known as dry mocks, allow trainees to practice these skills in realistic scenarios, gaining hands-on experience under professional supervision before working with actual donors. Without proper training, a collector risks producing inaccurate results, facing serious legal issues, and damaging professional credibility.

It’s also important to understand the differences between DOT and non-DOT collections. DOT collections must adhere to strict federal guidelines, such as testing commercial truck drivers to ensure public safety. In contrast, non-DOT tests align with internal company policies, industry standards, and state-specific regulations. Depending on career goals, various training pathways exist, whether working for an established facility or starting a new drug testing business (stationary or mobile).

When selecting a training provider, choose one that develops its programs in consultation with subject matter experts and attorneys. While training costs vary, beware of providers advertising “affordable” courses that often have outdated material and lack substance. The goal of becoming qualified is to learn, not merely to obtain a piece of paper. By investing in a high-quality training program, a prospective qualified collector will be better equipped to perform collections correctly, maintain compliance, and uphold professional standards.